Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1996 Aug;72(850):450–457. doi: 10.1136/pgmj.72.850.450

Gastric cancer.

P McCulloch 1
PMCID: PMC2398528  PMID: 8796206

Abstract

We are gaining a clearer insight into the causes and mechanisms of gastric carcinogenesis, and may be able to reduce the incidence in the future by Helicobacter pylori eradication, perhaps in conjunction with nutritional supplements. The work required to establish this kind of prevention programme still has a long way to go. Surveillance and early detection are a key area, and current hopes rest with an increasingly low threshold for gastroscopy together with improved awareness in both patients and general practitioners. Identification of a high-risk group for surveillance would be a major advance, and may become possible due to advances in molecular biology. In terms of treatment, surgery remains the mainstay, but for useful analysis of its' efficacy, uniform and detailed pathological staging is vital. Pre-operative assessment has improved greatly in recent years, resulting in fewer nontherapeutic laparotomies, thanks to a combination of improved imaging techniques and laparoscopy. Limited endoscopic surgery is now feasible for very early disease. The extent of radical surgery remains controversial: a strong argument can be made for concentrating this kind of surgery in the hands of a limited number of specialist units who will have the numbers and the expertise to answer the outstanding questions. Chemotherapy has yet to prove its value, but there are hopes that the newest regimes may do this. Treatment results in the West remain unsatisfactory, but they have improved in the last two decades, and should be capable of considerable further improvement.

Full text

PDF
450

Images in this article

451Figure
on p.451

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Takahashi M., Yabumoto E., Onoyama Y., Torizuka K. Techniques, indications and results of intraoperative radiotherapy of advanced cancers. Radiology. 1975 Sep;116(3):693–702. doi: 10.1148/116.3.693. [DOI] [PubMed] [Google Scholar]
  2. Bleiberg H., Gerard B., Deguiral P. Adjuvant therapy in resectable gastric cancer. Br J Cancer. 1992 Dec;66(6):987–991. doi: 10.1038/bjc.1992.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blot W. J., Li J. Y., Taylor P. R., Guo W., Dawsey S., Wang G. Q., Yang C. S., Zheng S. F., Gail M., Li G. Y. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993 Sep 15;85(18):1483–1492. doi: 10.1093/jnci/85.18.1483. [DOI] [PubMed] [Google Scholar]
  4. Bonenkamp J. J., Songun I., Hermans J., Sasako M., Welvaart K., Plukker J. T., van Elk P., Obertop H., Gouma D. J., Taat C. W. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995 Mar 25;345(8952):745–748. doi: 10.1016/s0140-6736(95)90637-1. [DOI] [PubMed] [Google Scholar]
  5. Buiatti E., Palli D., Decarli A., Amadori D., Avellini C., Bianchi S., Biserni R., Cipriani F., Cocco P., Giacosa A. A case-control study of gastric cancer and diet in Italy. Int J Cancer. 1989 Oct 15;44(4):611–616. doi: 10.1002/ijc.2910440409. [DOI] [PubMed] [Google Scholar]
  6. Bunt T. M., Bonenkamp H. J., Hermans J., van de Velde C. J., Arends J. W., Fleuren G., Bruijn J. A. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer. 1994 Mar 15;73(6):1544–1551. doi: 10.1002/1097-0142(19940315)73:6<1544::aid-cncr2820730604>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  7. Cho J. S., Kim J. K., Rho S. M., Lee H. Y., Jeong H. Y., Lee C. S. Preoperative assessment of gastric carcinoma: value of two-phase dynamic CT with mechanical iv. injection of contrast material. AJR Am J Roentgenol. 1994 Jul;163(1):69–75. doi: 10.2214/ajr.163.1.8010251. [DOI] [PubMed] [Google Scholar]
  8. Dent D. M., Madden M. V., Price S. K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988 Feb;75(2):110–112. doi: 10.1002/bjs.1800750206. [DOI] [PubMed] [Google Scholar]
  9. Ellias Y. A., Elias M. A., Gorey T. F. Early post-splenectomy sepsis after missile injury in adults. Ann R Coll Surg Engl. 1991 May;73(3):185–188. [PMC free article] [PubMed] [Google Scholar]
  10. Estape J., Grau J. J., Lcobendas F., Curto J., Daniels M., Viñolas N., Pera C. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up. Ann Surg. 1991 Mar;213(3):219–221. doi: 10.1097/00000658-199103000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  12. Fraser P., Chilvers C., Beral V., Hill M. J. Nitrate and human cancer: a review of the evidence. Int J Epidemiol. 1980 Mar;9(1):3–11. doi: 10.1093/ije/9.1.3. [DOI] [PubMed] [Google Scholar]
  13. Goseki N., Takizawa T., Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut. 1992 May;33(5):606–612. doi: 10.1136/gut.33.5.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gunderson L. L., Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):1–11. doi: 10.1016/0360-3016(82)90377-7. [DOI] [PubMed] [Google Scholar]
  15. Hallissey M. T., Allum W. H., Jewkes A. J., Ellis D. J., Fielding J. W. Early detection of gastric cancer. BMJ. 1990 Sep 15;301(6751):513–515. doi: 10.1136/bmj.301.6751.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hallissey M. T., Dunn J. A., Ward L. C., Allum W. H. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet. 1994 May 28;343(8909):1309–1312. doi: 10.1016/s0140-6736(94)92464-3. [DOI] [PubMed] [Google Scholar]
  17. Hisamichi S. Screening for gastric cancer. World J Surg. 1989 Jan-Feb;13(1):31–37. doi: 10.1007/BF01671151. [DOI] [PubMed] [Google Scholar]
  18. Holcombe C., Omotara B. A., Eldridge J., Jones D. M. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol. 1992 Jan;87(1):28–30. [PubMed] [Google Scholar]
  19. Holdstock G., Bruce S. Endoscopy and gastric cancer. Gut. 1981 Aug;22(8):673–676. doi: 10.1136/gut.22.8.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Irvin T. T., Bridger J. E. Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy. Br J Surg. 1988 Feb;75(2):106–109. doi: 10.1002/bjs.1800750205. [DOI] [PubMed] [Google Scholar]
  21. Kaibara N., Kawaguchi H., Nishidoi H., Kimura O., Okamoto T., Koga S., Fukumoto S. Significance of mass survey for gastric cancer from the standpoint of surgery. Am J Surg. 1981 Nov;142(5):543–545. doi: 10.1016/0002-9610(81)90421-9. [DOI] [PubMed] [Google Scholar]
  22. Kampschöer G. H., Nakajima T., van de Velde C. J. Changing patterns in gastric adenocarcinoma. Br J Surg. 1989 Sep;76(9):914–916. doi: 10.1002/bjs.1800760913. [DOI] [PubMed] [Google Scholar]
  23. Kerrigan D. D., Brown S. R., Hutchinson G. H. Open access gastroscopy: too much to swallow? BMJ. 1990 Feb 10;300(6721):374–376. doi: 10.1136/bmj.300.6721.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kwok S. P., Chung S. C., Griffin S. M., Li A. K. Devine exclusion for unresectable carcinoma of the stomach. Br J Surg. 1991 Jun;78(6):684–685. doi: 10.1002/bjs.1800780616. [DOI] [PubMed] [Google Scholar]
  25. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  26. Madden M. V., Price S. K., Learmonth G. M., Dent D. M. Surgical staging of gastric carcinoma: sources and consequences of error. Br J Surg. 1987 Feb;74(2):119–121. doi: 10.1002/bjs.1800740217. [DOI] [PubMed] [Google Scholar]
  27. Maehara Y., Orita H., Okuyama T., Moriguchi S., Tsujitani S., Korenaga D., Sugimachi K. Predictors of lymph node metastasis in early gastric cancer. Br J Surg. 1992 Mar;79(3):245–247. doi: 10.1002/bjs.1800790320. [DOI] [PubMed] [Google Scholar]
  28. Martin I. G., Dixon M. F., Sue-Ling H., Axon A. T., Johnston D. Goseki histological grading of gastric cancer is an important predictor of outcome. Gut. 1994 Jun;35(6):758–763. doi: 10.1136/gut.35.6.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987 Aug;11(4):418–425. doi: 10.1007/BF01655804. [DOI] [PubMed] [Google Scholar]
  30. McCulloch P. G., Ochiai A., O'Dowd G. M., Nash J. R., Sasako M., Hirohashi S. Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan. Cancer. 1995 Feb 15;75(4):920–925. doi: 10.1002/1097-0142(19950215)75:4<920::aid-cncr2820750405>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  31. McNeer G., Bowden L., Booner R. J., McPeak C. J. Elective total gastrectomy for cancer of the stomach: end results. Ann Surg. 1974 Aug;180(2):252–256. doi: 10.1097/00000658-197408000-00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer. 1977 Jun;39(6):2475–2485. doi: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  33. Molloy R. G., McCourtney J. S., Anderson J. R. Laparoscopy in the management of patients with cancer of the gastric cardia and oesophagus. Br J Surg. 1995 Mar;82(3):352–354. doi: 10.1002/bjs.1800820322. [DOI] [PubMed] [Google Scholar]
  34. Monson J. R., Donohue J. H., McIlrath D. C., Farnell M. B., Ilstrup D. M. Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer. 1991 Nov 1;68(9):1863–1868. doi: 10.1002/1097-0142(19911101)68:9<1863::aid-cncr2820680902>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  35. Moss A. A., Schnyder P., Marks W., Margulis A. R. Gastric adenocarcinoma: a comparison of the accuracy and economics of staging by computed tomography and surgery. Gastroenterology. 1981 Jan;80(1):45–50. [PubMed] [Google Scholar]
  36. Murugiah M., Paterson-Brown S., Windsor J. A., Miles W. F., Garden O. J. Early experience of laparoscopic ultrasonography in the management of pancreatic carcinoma. Surg Endosc. 1993 May-Jun;7(3):177–181. doi: 10.1007/BF00594102. [DOI] [PubMed] [Google Scholar]
  37. Nagata T., Ikeda M., Nakayama F. Changing state of gastric cancer in Japan. Histologic perspective of the past 76 years. Am J Surg. 1983 Feb;145(2):226–233. doi: 10.1016/0002-9610(83)90068-5. [DOI] [PubMed] [Google Scholar]
  38. Nakazato H., Koike A., Saji S., Ogawa N., Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet. 1994 May 7;343(8906):1122–1126. doi: 10.1016/s0140-6736(94)90233-x. [DOI] [PubMed] [Google Scholar]
  39. Nattermann C., Galbenu-Grünwald R., Nier H., Dancygier H. Endoskopischer Ultraschall im TN-Staging des Magenkarzinoms. Ein Vergleich mit der Computertomographie und der konventionellen Sonographie. Z Gesamte Inn Med. 1993 Feb;48(2):60–64. [PubMed] [Google Scholar]
  40. Nishida T., Haruma K., Tanaka S., Inoue K., Teshima H., Yoshihara M., Tari A., Sumii K., Kajiyama G. [Comparison of endoscopic therapy and conventional surgery for the treatment of early gastric cancer in elderly patients]. Nihon Ronen Igakkai Zasshi. 1993 May;30(5):376–381. doi: 10.3143/geriatrics.30.376. [DOI] [PubMed] [Google Scholar]
  41. Offerhaus G. J., Tersmette A. C., Giardiello F. M., Huibregtse K., Vandenbroucke J. P., Tytgat G. N. Evaluation of endoscopy for early detection of gastric-stump cancer. Lancet. 1992 Jul 4;340(8810):33–35. doi: 10.1016/0140-6736(92)92433-g. [DOI] [PubMed] [Google Scholar]
  42. Okamura T., Tsujitani S., Korenaga D., Haraguchi M., Baba H., Hiramoto Y., Sugimachi K. Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg. 1988 Mar;155(3):476–480. doi: 10.1016/s0002-9610(88)80116-8. [DOI] [PubMed] [Google Scholar]
  43. Okazaki Y., Tada M. Endoscopic treatment of early gastric cancer. Semin Surg Oncol. 1991 Nov-Dec;7(6):351–355. doi: 10.1002/ssu.2980070606. [DOI] [PubMed] [Google Scholar]
  44. Oleagoitia J. M., Echevarria A., Santidrian J. I., Ulacia M. A., Hernandez-Calvo J. Early gastric cancer. Br J Surg. 1986 Oct;73(10):804–806. doi: 10.1002/bjs.1800731015. [DOI] [PubMed] [Google Scholar]
  45. Pacelli F., Doglietto G. B., Bellantone R., Alfieri S., Sgadari A., Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg. 1993 Sep;80(9):1153–1156. doi: 10.1002/bjs.1800800930. [DOI] [PubMed] [Google Scholar]
  46. Paterson I. M., Easton D. F., Corbishley C. M., Gazet J. C. Changing distribution of adenocarcinoma of the stomach. Br J Surg. 1987 Jun;74(6):481–482. doi: 10.1002/bjs.1800740618. [DOI] [PubMed] [Google Scholar]
  47. Ramesar K. C., Sanders D. S., Hopwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J Clin Pathol. 1987 Nov;40(11):1287–1290. doi: 10.1136/jcp.40.11.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rothery G. A., Day D. W. Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa. J Clin Pathol. 1985 Jun;38(6):613–621. doi: 10.1136/jcp.38.6.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sasako M., McCulloch P., Kinoshita T., Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995 Mar;82(3):346–351. doi: 10.1002/bjs.1800820321. [DOI] [PubMed] [Google Scholar]
  50. Shimoyama Y., Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991 Apr 15;51(8):2185–2192. [PubMed] [Google Scholar]
  51. Siewert J. R., Böttcher K., Roder J. D., Busch R., Hermanek P., Meyer H. J. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993 Aug;80(8):1015–1018. doi: 10.1002/bjs.1800800829. [DOI] [PubMed] [Google Scholar]
  52. Soga J., Kobayashi K., Saito J., Fujimaki M., Muto T. The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg. 1979 Nov;3(6):701–708. doi: 10.1007/BF01654793. [DOI] [PubMed] [Google Scholar]
  53. Sue-Ling H. M., Johnston D. D1 versus D2 dissection for gastric cancer. Lancet. 1995 Jun 10;345(8963):1515–1518. [PubMed] [Google Scholar]
  54. Sue-Ling H. M., Johnston D., Martin I. G., Dixon M. F., Lansdown M. R., McMahon M. J., Axon A. T. Gastric cancer: a curable disease in Britain. BMJ. 1993 Sep 4;307(6904):591–596. doi: 10.1136/bmj.307.6904.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Sugimachi K., Kodama Y., Kumashiro R., Kanematsu T., Noda S., Inokuchi K. Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer. Gan. 1980 Oct;71(5):704–709. [PubMed] [Google Scholar]
  56. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265–272. doi: 10.1007/BF01212724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 1991 Jun 1;51(11):3056–3058. [PubMed] [Google Scholar]
  58. Tsukuma H., Mishima T., Oshima A. Prospective study of "early" gastric cancer. Int J Cancer. 1983 Apr 15;31(4):421–426. doi: 10.1002/ijc.2910310405. [DOI] [PubMed] [Google Scholar]
  59. Wils J. A., Klein H. O., Wagener D. J., Bleiberg H., Reis H., Korsten F., Conroy T., Fickers M., Leyvraz S., Buyse M. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol. 1991 May;9(5):827–831. doi: 10.1200/JCO.1991.9.5.827. [DOI] [PubMed] [Google Scholar]
  60. Ziegler K., Sanft C., Zimmer T., Zeitz M., Felsenberg D., Stein H., Germer C., Deutschmann C., Riecken E. O. Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut. 1993 May;34(5):604–610. doi: 10.1136/gut.34.5.604. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES